Moderna’s CEO says interim results are expected next month from a large clinical trial of the company’s coronavirus vaccine — one of several vaccines in the final phase of testing. If all goes well, the FDA could authorize emergency use by the end of the year. Internal medicine specialist and immunologist Dr. Neeta Ogden joined CBSN to weigh in on the latest developments.
